Meeting
2013 ASCO Annual Meeting
Evaluation of prevalence, number, and temporal changes of circulating tumor cells as assessed after 2 and 5 years of follow-up in patients with early breast cancer in the SUCCESS A study.
Authors
Emanuel C. A. Bauer
Department of Gynecology and Obstetrics, University Ulm, Ulm, Germany
Emanuel C. A. Bauer , Julia Katharina Neugebauer , Ulrich Andergassen , Bernadette Jaeger , Julia Kathrin Jueckstock , Peter A. Fasching , Lothar Haeberle , Thomas W. P. Friedl , Iris Schrader , Andreas Lorenz , Hans Tesch , Mahdi Rezai , Elisabeth Thurner-Herrmanns , Andreas Schneeweiss , Matthias W. Beckmann , Klaus Pantel , Wolfgang Janni , Brigitte Kathrin Rack
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Circulating Tumor Cells
Clinical Trial Registration Number
873037
Citation
J Clin Oncol 31, 2013 (suppl; abstr 11042)
DOI
10.1200/jco.2013.31.15_suppl.11042
Abstract #
11042
Poster Bd #
43E
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Persistence of circulating tumor cells in high risk early breast cancer patients five years after adjuvant chemotherapy and late recurrence: Results from the adjuvant SUCCESS A trial.
First Author: Wolfgang Janni
Poster
2021 ASCO Annual Meeting
Impact of dendritic cell vaccines added to neoadjuvant CT on pathological complete responses in early breast cancer patients according to PD-L1 expression.
First Author: Ignacio Ortego
Poster
2017 ASCO Annual Meeting
Chemotherapy-induced ovarian failure (CIOF) in young women with early breast cancer (EBC).
First Author: Jenny Furlanetto
Poster
2016 ASCO Annual Meeting
Changes in circulating tumor cell counts during the course of chemotherapy in women with high-risk early breast cancer.
First Author: Marie Lena Johanna Tzschaschel